Evidence map›Paper›PMID 39093038›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2024

Lifecourse Growth and Development Determinants of Mammographic Density in Black Women.

Zahna Bigham, Etienne X Holder, Angie Mae Rodday, Janis L Breeze, Kerrie P Nelson, Julie R Palmer, Karen M Freund, Kimberly A Bertrand

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Zahna BighamTufts University Graduate School of Biomedical Sciences, Boston, Massachusetts.ORCID 0000-0002-1544-1867
Etienne X HolderSlone Epidemiology Center at Boston University, Boston, Massachusetts.ORCID 0000-0003-0877-9058
Angie Mae RoddayTufts University Graduate School of Biomedical Sciences, Boston, Massachusetts.ORCID 0000-0002-8671-3401
Janis L BreezeInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.ORCID 0000-0002-5458-1010
Kerrie P NelsonDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.ORCID 0000-0002-1195-8105
Julie R PalmerSlone Epidemiology Center at Boston University, Boston, Massachusetts.ORCID 0000-0002-6534-335X
Karen M FreundTufts University Graduate School of Biomedical Sciences, Boston, Massachusetts.ORCID 0000-0002-9049-5574
Kimberly A BertrandSlone Epidemiology Center at Boston University, Boston, Massachusetts.ORCID 0000-0002-4565-7618

Funding

A Follow-up Study for Causes of Cancer in Black WomenU01CA164974 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Kimberly A. Bertrand, Yvette C Cozier · 2017 to 2026
$24.0M
A Follow-up Study for Causes of Cancer in Black WomenUM1CA164974 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENBERG, LYNN · 2012 to 2017
$13.7M
Mammographic density and breast cancer risk in African American womenR01CA214542 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BERTRAND, KIMBERLY A. · 2017 to 2020
$1.7M
Life Course Developmental and Reproductive Predictors of Increased Mammographic Breast Density in Black WomenF30CA271665 · NCI · TUFTS UNIVERSITY BOSTON · PI BIGHAM, ZAHNA · 2023 to 2025
$132k
American Cancer Society (ACS) CRP-17-112-06-COUNNational Cancer Institute (NCI) CA164974National Cancer Institute (NCI) CA214542National Cancer Institute (NCI) CA271665NCI NIH HHS F30 CA271665NCI NIH HHS R01 CA214542NCI NIH HHS U01 CA164974NCI NIH HHS UM1 CA164974Susan G. Komen (SGK) ASP231042218
6 · The paper itself

Abstract

backgroundHigh mammographic density is one of the strongest breast cancer risk factors; however, determinants of high mammographic density are understudied in Black women. We assessed growth and development factors across the lifecourse in relation to mammographic density.

methodsWithin the Black Women's Health Study, we used Cumulus software to assess percent mammographic density from digital screening mammograms for 5,905 women ages 40 to 74 years. We fit linear regression models to quantify the association of lifecourse characteristics including birthweight, childhood somatotype, age at menarche, body mass index (BMI) at age 18 years, height, BMI at mammography, and adulthood waist-to-hip ratio with density overall and by age. We also performed a path analysis to assess the total and mediating effects of the growth and development factors on density.

resultsBMI at age 18 years, height, BMI at mammography, and waist-to-hip ratio were significantly and inversely associated with density. On path analysis, total effects of childhood somatotype (standardized β = -0.05, P < 0.001), BMI at age 18 years (standardized β = -0.13, P < 0.001), BMI at mammography (standardized β = -0.22, P < 0.001), and waist-to-hip ratio (standardized β = -0.04, P < 0.001) were associated with density.

conclusionsSeveral factors across the lifecourse-greater childhood somatotype, BMI at age 18 years, height, BMI at mammography, and waist-to-hip ratio-were associated with lower mammographic density in this cohort of Black women. IMPACT: Body size closer to the time of mammography may be more meaningful in determining mammographic density, though early-life adiposity also influences mammographic density. See related In the Spotlight, p. 1541.

Indexed as

Black or African AmericanBreast DensityBreast NeoplasmsMammographyAdultAgedBody Mass IndexFemaleHumansMiddle AgedRisk Factors

Identifiers

PMID39093038
PMCPMC11611676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.